Page 28 - Johnson Medtech News Today

To bring quality cancer treatment closer to patients

Patient education and networking can empower cardiac arrest survivors, but the heart pump technology developer has found it also inspires and engages medical technologists and operators.

/PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced that positive results...

/PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced that positive results...

LOS ANGELES, CA. (PRWEB) January 31, 2023 -- MedTech Color (MTC)—the nonprofit organization with a mission to advance the representation of persons of color

Johnson & Johnson reported Q4 results that beat The Street on earnings but missed on revenue amid continued macroeconomic challenges. 

After several years of disruption and uncertainty, our medical device teams are ready for a fresh start. These 5 strategies will help your team work...

In this 2022 report, PatSnap outlines the future of wearable devices like fitness trackers and body sensors. The report discusses the impact these devices are having on the healthcare industry, as well as the IP and innovation trends they are creating.

This 2022 report from PatSnap discusses the future of wearable medical tech like fitness trackers and body sensors. The report explores IP and innovation trends such as patent applications, key players, and investment activity.

Along with Johnson & Johnson, Boston Scientific, and Medtronic were also among the winners at this year’s Irish Medtech Awards.